Patent · US Active

Imidazopyridines Syk inhibitors

US9562056B2 · kind B2 · utility

11Cited by

17References

7Claims

0Family size

Assignee

GILEAD CONNECTICUT, INC. · US

Inventors

Peter A. Blomgren · Issaquah, US
Kevin S. Currie · North Branford, US
Jeffrey E. Kropf · Branford, US
Seung H. Lee · Sammamish, US
Scott A. Mitchell · East Haven, US
Aaron C. Schmitt · Hamden, US
Jianjun Xu · Bellevue, US
Zhongdong Zhao · Guilford, US

Key dates

Filing date	Mar 11, 2011
Grant date	Feb 7, 2017
Priority date	—
Expiry date	Jan 28, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q1/485
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Certain imidazopyridines (I) and pharmaceutical compositions thereof are provided herein. Methods of treating patients suffering from certain diseases and disorders responsive to the inhibition of Syk activity, which comprises administering to such patients an amount of at least one chemical entity effective to reduce signs or symptoms of the disease or disorder are provided. Also provided are methods for determining the presence or absence of Syk kinase in a sample.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.